Share this article

Semler Scientific Tumbles After Market Close on Convertible Note Offering, Earnings

Fourth-quarter revenue and income from operations rose while the medical-devices company holds 2,321 BTC.

Updated Jan 24, 2025, 1:08 p.m. Published Jan 24, 2025, 9:57 a.m.
A hand adds another coin to a stack. (Shutterstock)
Semler Scientific is looking to raise funds for more bitcoin purchases. (Shutterstock)

What to know:

  • Semler Scientific shares dropped as much as 15% after the medical-devices maker announced its first convertible note offering and fourth-quarter earnings highlights.
  • The company plans to raise $85 million through the debt sale, with an option for an extra $15 million.
  • Most of the proceeds will be used to add to its bitcoin holdings.
  • Revenue rose to $12.5 million from $12.1 million and income from operations to $3.7 million from $3.4 million.

The analyst who wrote this piece owns shares of Semler Scientific (SMLR).

Medical-devices maker Semler Scientific (SMLR) tumbled as much as 15% after the close of U.S. trading on Thursday after saying it plans to sell $75 million of convertible senior notes and will use some of the funds to add to its bitcoin (BTC) holdings.

The shares dropped as low as $51 and were recently indicated 8% lower in pre-market trading. The Santa Clara, Calif.-based company increased the offering size to $85 million with an additional $15 million option available. The notes, which expire in 2030, carry a 4.25% annual interest rate.

STORY CONTINUES BELOW
Don't miss another story.Subscribe to the Crypto Daybook Americas Newsletter today. See all newsletters

Semler set an initial conversion price of $76.44, representing a 2% premium over the stock's closing price Thursday. The notes are redeemable after August 2028, provided the stock price reaches 130% of the conversion price.

Of the proceeds, $6.6 million will fund capped-call transactions that will limit existing investors' equity dilution, and the rest will go towards bitcoin acquisitions and general corporate purposes.

Fourth-quarter revenue rose 3.3% to $12.5 million and income from operations added 8.8% to $3.7 million, the company said. The unrealized gain from the change in fair value of bitcoin holdings was about $29 million.

As of Jan. 17, Semler Scientific held 2,321 BTC, with an aggregate purchase price of $191.9 million and an average price of $82,689.

UPDATE (Jan. 24, 13:06 UTC): Adds increased sale, interest rate other details starting in second paragraph.


More For You

'We do not do illegal things': Inside a U.S.-sanctioned stablecoin issuer's race to build a crypto giant

Oleg Ogienko, director for regulatory and overseas affairs at A7A5, at Consensus in Hong Kong (provided)

Oleg Ogienko, the public face of A7A5, pitched the ruble-pegged stablecoin as a fast-growing trade rail built to move money across borders despite sanctions pressure.

What to know:

  • Oleg Ogienko, the public face of ruble-denominated stablecoin issuer A7A5, insists the firm complies fully with Kyrgyz regulations and international anti-money-laundering standards despite extensive U.S. sanctions on its affiliates.
  • A7A5, whose issuing entities and reserve bank are sanctioned by the U.S. Treasury, has grown faster than USDT and USDC and aims to handle more than 20 percent of Russia’s trade settlements, primarily serving businesses in Asia, Africa and South America trading with Russian partners.
  • Ogienko said that he and his team were developing partnerships with blockchain platforms and exchanges during Consensus in Hong Kong, though declined to name specifics.